search
Back to results

Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years (AMPAGE)

Primary Purpose

Infertilities

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
In Vitro Fecundation (IVF)
Intra Uterine Insemination (IUI)
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Infertilities focused on measuring Infertility, female age, intra-uterine insemination, in vitro fecundation, assisted reproductive technology center

Eligibility Criteria

37 Years - 42 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Female age between 37 and 42 years at the time of inclusion
  • Infertility duration ≥ 12 months
  • Normal tubes
  • No severe endometriosis
  • At least 1.5 106 motile spermatozoa to be inseminated
  • No previous ART attempt

Exclusion Criteria:

  • Tubal abnormalities
  • Severe endometriosis
  • Less than 1.5 106 motile spermatozoa to be inseminated
  • Use of frozen sperm
  • Presence of anti-spermatozoa antibodies

Sites / Locations

  • University Hospital
  • CHU Bordeaux Hôpital Pellegrin
  • CHRU Brest Hôpital Morvan, service d'AMP
  • Centre Hospitalier Intercommunal de Créteil, Service d'AMP
  • CHU Dijon Laboratoire de biologie de la reproduction
  • Institut de Médecine de la Reproduction
  • CHU Montpellier, Médecine de la Reproduction
  • CHU Nantes centre d'AMP
  • CHU Nice centre d'AMP
  • CHI Poissy St-Germain en Laye, centre d'AMP
  • Centre Hospitalier des Quatre Villes, Saint-Cloud Service de Médecine de la Reproduction
  • CHU de Strasbourg, Centre d'AMP

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

In Vitro Fecundation (IVF)

Intra Uterine Insemination (IUI)

Arm Description

Couples will be treated by In Vitro Fecundation (IVF)

Couples will be treated by Intra Uterine Insemination (IUI)

Outcomes

Primary Outcome Measures

Delivery rate.

Secondary Outcome Measures

Multiple pregnancy rate
Cost of treatment
Adverse effects (hyperstimulation, infections…)

Full Information

First Posted
November 22, 2013
Last Updated
July 11, 2019
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT02001870
Brief Title
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
Acronym
AMPAGE
Official Title
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Terminated
Why Stopped
Recuitment target non obtained
Study Start Date
May 2014 (Actual)
Primary Completion Date
July 2019 (Actual)
Study Completion Date
July 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
As age increases the chances for a woman to become pregnant decrease as well spontaneously as through assisted reproductive technologies (ART). For the treatment of unexplained infertilities two techniques can be used: intra-uterine insemination (IUI) and in vitro fertilization (IVF). The aim of the present study is to compare the efficiency in term of delivery rate of IUI and IVF in couples in whom the female age is over 37 years.
Detailed Description
IUI can be used to treat infertility when tubes are normal, with no severe endometriosis and enough motile spermatozoa can be inseminated. In these cases IUI are usually performed (4 to 6 attempts) and IVF only in case of IUI failure. Indeed if the pregnancy rate per attempt is higher with IVF, IUI can be performed more frequently (6 times a year vs. 2 for IVF) so that the pregnancy rates after one year of treatment are close. When female age is over 37 years, some ART centers prefer to perform directly IVF, since chances of pregnancy decreases with time. However there is no argument in the literature in favor as well as in disfavor for such an attitude. Indeed the delivery rates after one year treatment with IUI or IVF are not known in this population. Therefore we propose a multicentric randomized controlled trial comparing IUI and IVF in women over 37 with unexplained infertility. Couples will be randomly allocated to IUI or IVF during one year. In case of absence of pregnancy after 4 IUI, couples will be treated by IVF. ART attempts will be performed according to usual procedures of each center. The follow-up will be ended either at the end of the first year of treatment if no pregnancy is obtained or at the time of delivery if a pregnancy is obtained. All data of attempts (demographics data, type and doses of treatment, adverse effects, outcome, number and health state of newborns....) will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertilities
Keywords
Infertility, female age, intra-uterine insemination, in vitro fecundation, assisted reproductive technology center

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
88 (Actual)

8. Arms, Groups, and Interventions

Arm Title
In Vitro Fecundation (IVF)
Arm Type
Experimental
Arm Description
Couples will be treated by In Vitro Fecundation (IVF)
Arm Title
Intra Uterine Insemination (IUI)
Arm Type
Active Comparator
Arm Description
Couples will be treated by Intra Uterine Insemination (IUI)
Intervention Type
Procedure
Intervention Name(s)
In Vitro Fecundation (IVF)
Intervention Description
In vivo fertilization will be performed according to the usual procedure of each Assisted Reproductive Technology (ART) center.
Intervention Type
Procedure
Intervention Name(s)
Intra Uterine Insemination (IUI)
Intervention Description
Intra-uterine insemination will be performed according to the usual procedure of each ART center
Primary Outcome Measure Information:
Title
Delivery rate.
Time Frame
After one year of treatment.
Secondary Outcome Measure Information:
Title
Multiple pregnancy rate
Time Frame
After one year of treatment.
Title
Cost of treatment
Time Frame
After one year of treatment.
Title
Adverse effects (hyperstimulation, infections…)
Time Frame
After one year of treatment.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
37 Years
Maximum Age & Unit of Time
42 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Female age between 37 and 42 years at the time of inclusion Infertility duration ≥ 12 months Normal tubes No severe endometriosis At least 1.5 106 motile spermatozoa to be inseminated No previous ART attempt Exclusion Criteria: Tubal abnormalities Severe endometriosis Less than 1.5 106 motile spermatozoa to be inseminated Use of frozen sperm Presence of anti-spermatozoa antibodies
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean PARINAUD, MD
Organizational Affiliation
University Hospital of Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital
City
Toulouse
State/Province
Midi-Pyrénnées
ZIP/Postal Code
31059
Country
France
Facility Name
CHU Bordeaux Hôpital Pellegrin
City
Bordeaux
Country
France
Facility Name
CHRU Brest Hôpital Morvan, service d'AMP
City
Brest
Country
France
Facility Name
Centre Hospitalier Intercommunal de Créteil, Service d'AMP
City
Créteil
Country
France
Facility Name
CHU Dijon Laboratoire de biologie de la reproduction
City
Dijon
Country
France
Facility Name
Institut de Médecine de la Reproduction
City
Marseille
Country
France
Facility Name
CHU Montpellier, Médecine de la Reproduction
City
Montpellier
Country
France
Facility Name
CHU Nantes centre d'AMP
City
Nantes
Country
France
Facility Name
CHU Nice centre d'AMP
City
Nice
Country
France
Facility Name
CHI Poissy St-Germain en Laye, centre d'AMP
City
Poissy
Country
France
Facility Name
Centre Hospitalier des Quatre Villes, Saint-Cloud Service de Médecine de la Reproduction
City
Saint-Cloud
Country
France
Facility Name
CHU de Strasbourg, Centre d'AMP
City
Strasbourg
Country
France

12. IPD Sharing Statement

Learn more about this trial

Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years

We'll reach out to this number within 24 hrs